Trial Profile
A Prospective Feasibility Study to Evaluate the Safety and Performance of the Exhale(R) Drug-Eluting Stent System in Patients With Emphysema
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 07 Dec 2015
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Emphysema
- Focus Adverse reactions; Therapeutic Use
- Sponsors Broncus Technologies
- 22 May 2014 New trial record
- 22 Jan 2008
- 31 Oct 2006